Self-DNA release and STING-dependent sensing drives inflammation to cigarette smoke in mice

Archive ouverte

Nascimento, Mégane | Gombault, Aurélie | Lacerda-Queiroz, Norinne | Panek, Corinne | Savigny, Florence | Sbeity, Malak | Bourinet, Manon | Le Bert, Marc | Riteau, Nicolas | Ryffel, Bernhard | Quesniaux, Valérie | Couillin, Isabelle

Edité par CCSD ; Nature Publishing Group -

International audience. Cigarette smoke exposure is a leading cause of chronic obstructive pulmonary disease (COPD), a major health issue characterized by airway inflammation with fibrosis and emphysema. Here we demonstrate that acute exposure to cigarette smoke causes respiratory barrier damage with the release of self-dsDNA in mice. This triggers the DNA sensor cGAS (cyclic GMP-AMP synthase) and stimulator of interferon genes (STING), driving type I interferon (IFN I) dependent lung inflammation, which are attenuated in cGAS, STING or type I interferon receptor (IFNAR) deficient mice. Therefore, we demonstrate a critical role of self-dsDNA release and of the cGAS-STING-type I interferon pathway upon cigarette smoke-induced damage, which may lead to therapeutic targets in COPD.

Suggestions

Du même auteur

B-Cell Activating Factor Secreted by Neutrophils Is a Critical Player in Lung Inflammation to Cigarette Smoke Exposure

Archive ouverte | Nascimento, Mégane | CCSD

International audience

Cigarette smoke-induced gasdermin D activation in bronchoalveolar macrophages and bronchial epithelial cells dependently on NLRP3

Archive ouverte | Huot-Marchand, Sarah | CCSD

International audience. Chronic pulmonary inflammation and chronic obstructive pulmonary disease (COPD) are major health issues largely due to air pollution and cigarette smoke (CS) exposure. The role of the innate ...

Protective role of the nucleic acid sensor STING in pulmonary fibrosis Running title: STING protects against IPF

Archive ouverte | Savigny, Florence | CCSD

International audience. Idiopathic pulmonary fibrosis (IPF) is the most common and severe type of interstitial lung disease for which current treatments display limited efficacy. IPF is largely driven by host-derive...

Chargement des enrichissements...